Shanghai Xuerong Biotechnology Co Ltd
SZSE:300511
Intrinsic Value
Shanghai Xuerong Bio-Technology Co., Ltd. engages in the research, production, and marketing of modern bio-agricultural products. [ Read More ]
The intrinsic value of one Shanghai Xuerong Biotechnology Co Ltd stock under the Base Case scenario is 6.5 CNY. Compared to the current market price of 3.25 CNY, Shanghai Xuerong Biotechnology Co Ltd is Undervalued by 50%.
Valuation Backtest
Shanghai Xuerong Biotechnology Co Ltd
Run backtest to discover the historical profit from buying and selling Shanghai Xuerong Biotechnology Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Shanghai Xuerong Biotechnology Co Ltd
| Current Assets | 997m |
| Cash & Short-Term Investments | 400.8m |
| Receivables | 46.3m |
| Other Current Assets | 549.8m |
| Non-Current Assets | 3.1B |
| Long-Term Investments | 21.3m |
| PP&E | 2.8B |
| Intangibles | 286.8m |
| Other Non-Current Assets | 39.1m |
| Current Liabilities | 1.3B |
| Accounts Payable | 231.3m |
| Accrued Liabilities | 62.9m |
| Short-Term Debt | 566.3m |
| Other Current Liabilities | 433.1m |
| Non-Current Liabilities | 989.2m |
| Long-Term Debt | 1B |
| Other Non-Current Liabilities | -12.9m |
Earnings Waterfall
Shanghai Xuerong Biotechnology Co Ltd
|
Revenue
|
2.6B
CNY
|
|
Cost of Revenue
|
-2.3B
CNY
|
|
Gross Profit
|
275m
CNY
|
|
Operating Expenses
|
-678.5m
CNY
|
|
Operating Income
|
-403.6m
CNY
|
|
Other Expenses
|
-17.9m
CNY
|
|
Net Income
|
-421.5m
CNY
|
Free Cash Flow Analysis
Shanghai Xuerong Biotechnology Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Shanghai Xuerong Biotechnology Co Ltd's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
Score
Shanghai Xuerong Biotechnology Co Ltd's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Shanghai Xuerong Biotechnology Co Ltd's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Score
Shanghai Xuerong Biotechnology Co Ltd's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Shanghai Xuerong Biotechnology Co Ltd
According to Wall Street analysts, the average 1-year price target for Shanghai Xuerong Biotechnology Co Ltd is 10.7 CNY .
Shareholder Return
Price
Shanghai Xuerong Biotechnology Co Ltd
| Average Annual Return | 1.76% |
| Standard Deviation of Annual Returns | 61.08% |
| Max Drawdown | -84% |
| Market Capitalization | 1.6B CNY |
| Shares Outstanding | 498 781 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Shanghai Xuerong Bio-Technology Co., Ltd. engages in the research, production, and marketing of modern bio-agricultural products. The company is headquartered in Shanghai, Shanghai and currently employs 1,712 full-time employees. The company went IPO on 2016-05-04. is a China-based modern agricultural company principally engaged in the production of factory cultivated agricultural products. The firm is mainly engaged in the research and development, factory cultivation and sale of fresh edible mushrooms. The firm's main products include enoki mushrooms, hypsizygus tessellatus (including beech mushrooms, white beech mushrooms and hypsizygus marmoreus) and shiitake, among others. The firm distributes its products in domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Shanghai Xuerong Biotechnology Co Ltd stock under the Base Case scenario is 6.5 CNY.
Compared to the current market price of 3.25 CNY, Shanghai Xuerong Biotechnology Co Ltd is Undervalued by 50%.
You don't have any saved screeners yet
